Effect of OFE on the Mild Cognitive Impairment

Not Applicable

Completed

• Conditions: Mental and behavioral disorders

• Registration Number: KCT0003766
• Lead Sponsor: Koreaeundan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 23 April 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

With subjective memory complaints
With Literacy
Who have scores in memroy domains of CERAD-K below -1.0 SD
Who agree informed consent

Exclusion Criteria

Inpatient or within 3 months after discharge with malignancy, severe cerebrovascular diseasd, severe cardiac disease
Schizophrenia, major depressive disorder
Dementia, Parkinson disease, cerebral infarction
The patient who taking the cerebral enhancer test before 4 weeks
The patient who taking more than 400IU of vitamin E
Alcohol abuse or dependence
Thyroid disease
Renal or hepatic dysfunction
Uncontrolled high blood glucose and high blood preasure
Pregnancy or breast feeding
The patient who involved with 3 months with other human clinical trial
The patient who is not suitable for this clinical trial by investigator

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total score of Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog);memory score of ADAS-cog;Alzeheimer's Disease Assement Scale-Korean Version (ADAS-K);Visual Continuous Performance Test (Visual CPT);Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL);Short form of Geriatric Depression Sclae (SGDS)

Secondary Outcome Measures

Name	Time	Method
Side effect;Laboratory tests;Vital signs;Weight